Genemod is a biotechnology and health care startup based in the United States. Founded in 2018, the company's slogan is "Modern day lab inventory and project management on a single, shared platform." Genemod aims to accelerate life sciences R&D by improving collaboration for every team in a hybrid workspace, allowing scientists to focus on big ideas without getting bogged down in busywork. The company's last investment was a $4.50M Seed Round investment on 01 May 2023, with participation from a diverse group of investors including Looking Glass Capital, Vulcan Capital, Dolby Ventures, LDV Partners, Futureland Ventures, and Defy.vc. Genemod's proposition of bringing teams' work together in a shared space and streamlining process management to minimize repetitive tasks reflects its vision to enhance productivity for scientists and researchers. The platform's potential to simplify project management and inventory tracking within the life sciences industry positions Genemod as an innovative and valuable player in the market. With the recent investment, the company is poised to further develop its platform and expand its reach in the life sciences sector.
No recent news or press coverage available for Genemod.